In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model
November 17th, 2018
10.8K views
We describe a non-invasive in vivo imaging protocol that is streamlined and cost-effective, utilizing L-012, a chemiluminescent luminol-analog, to visualize and quantify reactive oxygen species (ROS) generated in a mouse excisional wound model.
Overview
This article presents a non-invasive in vivo imaging protocol utilizing L-012, a chemiluminescent luminol-analog, to visualize and quantify reactive oxygen species (ROS) in a mouse excisional wound model. The method allows for real-time measurement of ROS, providing insights into tissue repair and regeneration.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Tissue Repair
Background
- Reactive oxygen species (ROS) play a significant role in wound healing.
- Understanding the relationship between oxidative stress and tissue regeneration is crucial.
- Current methods for measuring ROS can be invasive and complex.
- This study aims to simplify the imaging process while maintaining accuracy.
Purpose of Study
- To develop a streamlined protocol for in vivo imaging of ROS.
- To investigate the impact of ROS on tissue regeneration in a wound model.
- To enhance understanding of cytoprotective pathways in wound healing.
Methods Used
- Use of L-012 for chemiluminescent imaging of ROS.
- Application of the method in a mouse excisional wound model.
- Real-time monitoring of ROS levels during the healing process.
- Preparation of diabetic mice for the experiment.
Main Results
- Successful visualization of ROS in real-time during wound healing.
- Demonstrated the correlation between ROS levels and tissue regeneration.
- Provided insights into the role of oxidative stress in healing.
- Validated the non-invasive nature of the imaging protocol.
Conclusions
- The developed protocol is effective for studying ROS in vivo.
- This method can advance research in tissue repair and regeneration.
- Future studies can build on these findings to explore therapeutic interventions.
Frequently Asked Questions
What is the significance of measuring ROS in wound healing?
Measuring ROS helps understand their role in tissue regeneration and the healing process.
How does this method compare to traditional imaging techniques?
This method is non-invasive and allows for real-time monitoring, making it more efficient.
What are the potential applications of this imaging protocol?
It can be used to study various aspects of tissue repair and the effects of different treatments.
Who conducted the study?
The study was conducted by researchers in a laboratory led by Jennifer Kwong.
What type of mice were used in the experiments?
Diabetic mice aged eight to twelve weeks were used for the study.
Can this method be applied to other types of wounds?
Yes, the protocol can potentially be adapted for various wound models.
Executive Industry Relevance
Real-time quantification of reactive oxygen species (ROS) in vivo enables mechanistic de-risking of wound healing therapeutics by linking oxidative stress dynamics to tissue regeneration outcomes. This approach supports target validation in inflammatory pathways and improves predictive confidence in preclinical models of diabetic wound repair. The method reduces animal use through longitudinal imaging, aligning with 3Rs principles while providing spatiotemporal data critical for lead identification and assay development in oxidative stress-related indications.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates the Nrf2/Keap1 pathway’s role in ROS homeostasis during wound healing, enabling target hypothesis testing.
- Operational Value: Provides quantitative, spatially resolved ROS readouts that clarify pathway modulation efficacy.
- Predictive Value: Supports go/no-go decisions by correlating ROS levels with healing trajectories in diabetic models.
Screening & Assay Development
- Scientific Value: Enables development of chemiluminescent assays for ROS detection with high sensitivity and temporal resolution.
- Operational Value: Standardizes ROS measurement across time points, reducing variability in compound screening campaigns.
- Scalability: Facilitates longitudinal monitoring in the same animal, increasing data yield per subject and supporting adaptive study designs.
Translational & Preclinical Research
- Scientific Value: Links ROS dynamics to histological endpoints like macrophage infiltration (F4/80) and cellularity, validating imaging biomarkers.
- Operational Value: Enables non-invasive tracking of oxidative stress from acute injury through remodeling phases.
- Translational Continuity: Supports extrapolation of mechanistic findings to human wound healing contexts via conserved redox pathways.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through preclinical efficacy testing, particularly for compounds targeting oxidative stress in chronic wounds.
- Discovery Biology: Tests mechanistic hypotheses about cytoprotective pathways (e.g., Nrf2) in regulating ROS during tissue repair.
- Screening: Generates quantitative bioluminescence readouts that enable dose-response assessment of antioxidant or pathway-modulating compounds.
- Analytics: Provides time-series ROS flux data from wound regions of interest, enabling kinetic analysis of intervention effects.
- Translational Research: Correlates imaging outputs with histological validation (H&E, F4/80) to strengthen biomarker qualification.
- Enterprise Reuse: Establishes a reusable imaging platform for oxidative stress assessment across multiple wound and inflammation models.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in wound healing by providing direct, real-time ROS measurements in intact tissue.
- Operational Value: Standardizes ROS detection via a sensitive, reproducible chemiluminescent readout with defined saturation kinetics (~50 min post-injection).
- Strategic Value: Improves capital efficiency by enabling early de-risking of targets through non-invasive longitudinal monitoring.
- Portfolio Impact: Supports risk-adjusted advancement by validating target engagement via ROS modulation in disease-relevant models.
Implementation Considerations
- Requires expertise in murine wound modeling, bioluminescence imaging, and intraperitoneal injection techniques.
- Dependent on access to a bioluminescence imaging system with environmental chamber controls (O2, inflow).
- Necessitates light-protected handling and preparation of L-012 solution to maintain signal integrity.
- Requires standardization of wound splinting and dressing protocols to minimize confounding variables in ROS signal detection.
- Limited to chemiluminescent-detectable ROS species; does not distinguish between specific ROS types without complementary probes.
Biopharma FAQs
Why does null hypothesis testing matter for ROS quantification in wound healing?
Null hypothesis testing determines whether observed changes in bioluminescence signal after L-012 injection represent statistically significant ROS elevation above baseline, which is essential for validating the sensitivity of the imaging assay in diabetic wound models.
How does isolating the independent variable (e.g., Keap1 knockdown) improve target validation in this ROS imaging assay?
By applying experimental siKeap1 gel versus control siRNA to wounds, the study isolates the effect of Nrf2 pathway modulation on ROS levels, enabling causal inference about target engagement in oxidative stress regulation during healing.
What quantitative dependent variable measurements enable ROS level comparison across experimental groups?
ROS levels are quantified by dividing total bioluminescence counts by the wound area of interest, generating a normalized intensity metric that allows comparison between nonsense and Keap1 siRNA-treated groups over time.
Why do replication requirements matter for ensuring reliable ROS measurements in multi-site wound studies?
Replication across bilateral wounds and multiple animals ensures that observed ROS differences are not due to surgical variability, supporting robust statistical analysis and cross-functional trust in the assay’s reproducibility.
What statistical analysis capabilities are required before implementing longitudinal ROS imaging in preclinical studies?
Implementation requires capacity for repeated-measures analysis of bioluminescence signals over time, including baseline correction, area normalization, and comparison of area-under-the-curve or peak signal between treatment groups to assess intervention effects.
Chapters in this video
0:04
Title
0:36
Murine Excisional Wound Healing Model Preparation (Day 0)
1:51
Keap1 siRNA (Day 1) and L-012 Solution Preparation and In Vivo Diabetic Wound Imaging (Day 3)
4:01
Results: Representative Reactive Oxygen Species (ROS) Quantification and Analysis
6:04
Conclusion
